desk
Share
In the financial year 2025, foreign institutional investors (FIIs) have sold a net Rs 1,27,401 crore. In March, this sale declined to Rs 3,972.61 crore. In contrast, domestic institutional investors (DIIs) remained buyers throughout the year and bought shares worth Rs 6,06,368 crore. In March, DIIs bought shares worth Rs 37,079.08 crore.
On Friday, FIIs sold shares worth Rs 4,352.82 crore, while DIIs bought shares worth Rs 7,646.49 crore. FIIs sold shares in seven months on an annual basis. The highest selling was in October and January. During this period, FIIs sold shares worth Rs 94,017 crore and Rs 78,027 crore respectively.
Domestic investors did not make net sales in any month
FIIs bought in June, July, August, September and December, with September buying the highest amount of shares worth Rs 57,724 crore. DIIs remained positive in the stock market throughout the year and did not make net sales in any month. DIIs made the highest purchases in October and January, Rs 1,07,255 crore and Rs 86,592 crore respectively. The market recovered after 5 months due to the return of FIIs. VK Vijaykumar, Chief Investment Strategist, Geojit Investments, said that the change in the strategy of FIIs became evident in the week ending March 21 and it gained momentum in the next week. In the last fifteen days, Nifty has seen a gain of about 6% on the back of FIIs' buying. This happened after a decline of the last five months, which was the longest period since the inception of Nifty in 1996. FIIs returned due to these three reasons . Vijaykumar listed three major reasons behind this and said that Nifty slipped by 16% from its September high to February, after which the valuations became attractive. Secondly, the recent return of the rupee's rise showed a change in the attitude towards American investment. Finally, the improvement in India's GDP, IIP and retail inflation rate also supported the market. Talking about the future, the flow of FIIs will mainly depend on the reciprocal tariff to be announced by the US. If this tariff is not too big, the current rally may continue.
Read More: Trump's tariff will wreak havoc on life saving medicines too, know how it will affect India
--Advertisement--
